Engineered immune cells boost leukemia survival for some
Patients with low disease load had best outcomes in first long-term look
IMMUNE ATTACK Doctors can engineer a patient’s own immune cells to kill cancer cells. These engineered cells, called CAR-T cells, were effective for some people against relapses of leukemia over the long term. Here, a CAR-T cell (red) attacks a leukemia cell (yellow).
Eye of Science/Science Source